clinical trial · NCT07931521
Clinical Trial to Evaluate the Safety and Efficacy of DW4421 in Patients With Erosive Reflux Disease
Daewon Pharmaceutical Co., Ltd.·phase3·completed·n = 328
Erosive Reflux DiseaseGERD (Gastroesophageal Reflux Disease)DW4421 20mgDW4421 40mgEsomeprazole 40mg
brief summary
This study aims to compare the efficacy and safety of DW4421 to Esomeprazole in patients with Erosive Reflux Disease.
started
Nov 17, 2025
primary completion
Aug 31, 2026
completion
Sep 14, 2026
last updated
Nov 12, 2026
official title
A Randomized, Double-Blind, Active-Controlled, Parallel, Multi-Center, Phase 3 Trial to Evaluate the Efficacy and Safety of DW4421 in Patients With Erosive Reflux Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol